<DOC>
	<DOCNO>NCT00534248</DOCNO>
	<brief_summary>This study look well Zostavax™ work prevent shingle participant age 50-59 year old .</brief_summary>
	<brief_title>Study Evaluate Safety Effectiveness Zostavax™ Subjects 50 - 59 Years Age ( V211-022 )</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Must 50 59 year age No fever day vaccination Females reproductive potential must willing use acceptable form birth control Have receive chicken pox shingle vaccine Have already shingle Have recently another vaccination Pregnant breast feeding . Have participate another research study last 30 day You take certain antiviral drug History allergic reaction vaccine component , include gelatin neomycin</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>